BARCLAYS PLC - FIVE PRIME THERAPEUTICS INC ownership

FIVE PRIME THERAPEUTICS INC's ticker is FPRX and the CUSIP is 33830X104. A total of 114 filers reported holding FIVE PRIME THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 1.98 and the average weighting 0.1%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of FIVE PRIME THERAPEUTICS INC
ValueSharesWeighting
Q1 2021$5,136,000
+2520.4%
136,346
+1081.7%
0.00%
Q4 2020$196,000
-79.9%
11,538
-94.4%
0.00%
-100.0%
Q3 2020$973,000
+731.6%
207,203
+975.9%
0.00%
Q2 2020$117,000
+134.0%
19,258
-12.0%
0.00%
Q1 2020$50,000
-76.1%
21,874
-52.0%
0.00%
Q4 2019$209,000
+72.7%
45,533
+45.7%
0.00%
Q3 2019$121,000
-39.8%
31,246
-6.6%
0.00%
Q2 2019$201,000
-31.6%
33,453
+52.6%
0.00%
Q1 2019$294,000
+100.0%
21,927
+38.4%
0.00%
Q4 2018$147,000
-72.5%
15,848
-58.7%
0.00%
Q3 2018$534,000
+612.0%
38,354
+704.1%
0.00%
Q2 2018$75,000
-82.8%
4,770
-81.3%
0.00%
Q1 2018$437,000
+183.8%
25,447
+261.8%
0.00%
Q4 2017$154,000
-62.7%
7,033
-30.5%
0.00%
Q3 2017$413,000
+48.6%
10,115
+9.4%
0.00%
Q2 2017$278,000
-50.5%
9,249
-40.5%
0.00%
-100.0%
Q1 2017$562,000
+46.0%
15,544
+102.1%
0.00%
Q4 2016$385,000
+47.5%
7,690
+54.7%
0.00%
Q3 2016$261,000
+186.8%
4,972
+128.3%
0.00%
Q2 2016$91,000
-98.9%
2,178
-98.9%
0.00%
-100.0%
Q1 2016$8,093,000
+11.6%
202,347
+14.4%
0.01%
+33.3%
Q4 2015$7,253,000
+4116.9%
176,922
+1445.4%
0.01%
Q3 2015$172,000
+45.8%
11,448
+133.8%
0.00%
Q2 2015$118,000
+413.0%
4,897
+388.7%
0.00%
Q1 2015$23,000
-14.8%
1,002
+2.0%
0.00%
Q4 2014$27,000
+350.0%
982
+73.5%
0.00%
Q3 2014$6,000
+20.0%
566
+68.0%
0.00%
Q2 2014$5,000
-28.6%
337
-10.1%
0.00%
Q1 2014$7,000
+600.0%
375
+312.1%
0.00%
Q4 2013$1,000910.00%
Other shareholders

There were no reported owners of FIVE PRIME THERAPEUTICS INC in Q1 2019.

NameSharesValueWeighting ↓
View complete list of FIVE PRIME THERAPEUTICS INC shareholders